Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia	Albuminuria, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypoxia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, proteinuria, type 1 diabetes mellitus, urinary system disorder	Not yet recruiting	Phase 2	2025-01-27		NCT06147232

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Glostrup University Hospital, Copenhagen	15
Guy's and St Thomas' NHS Foundation Trust	118
Juvenile Diabetes Research Foundation	33
King's College London	203
Steno Diabetes Center Copenhagen	41

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guy's and St Thomas NHS Trust	London	United Kingdom	1
Steno Diabetes Center Copenhagen	Herlev	Denmark	18